The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Wang Y, Dong S, Hu K, Xu L, Feng Q, Li B, Wang G, Chen G, Zhang B, Jia X, Xu Z, Gao X, Zhang H, Xie Y, Lu M, Chang S, Song D, Wu X, Jia Q, Zhu H, Zhou J, Zhu W, Shi J.
Wang Y, et al.
J Transl Med. 2023 Nov 27;21(1):858. doi: 10.1186/s12967-023-04739-7.
J Transl Med. 2023.
PMID: 38012658
Free PMC article.